{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T06:16:44Z","timestamp":1764569804374,"version":"3.46.0"},"reference-count":25,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"unspecified","delay-in-days":150,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"the Guangxi Natural Science Foundation","award":["2023GXNSFAA026247, 2024GXNSFAA010019"],"award-info":[{"award-number":["2023GXNSFAA026247, 2024GXNSFAA010019"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Neurol Open"],"accepted":{"date-parts":[[2025,11,13]]},"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Variants in the\n                      <jats:italic>FHL1<\/jats:italic>\n                      gene are associated with a spectrum of rare X-linked hereditary myopathies. This study describes the clinical presentation and genetic basis of a novel\n                      <jats:italic>FHL1<\/jats:italic>\n                      variant identified in a Chinese family with an inherited myopathy, aiming to delineate its phenotypic and genotypic characteristics.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Clinical data were collected from two symptomatic family members. The proband underwent a muscle biopsy. Genetic analysis was performed using whole-exome sequencing and Sanger sequencing of peripheral blood DNA. Bioinformatic tools were employed to predict the pathogenicity of the variant and its impact on protein structure and stability. Wild-type and mutant\n                      <jats:italic>FHL1<\/jats:italic>\n                      constructs were transfected into 293\u2009T cells to compare mRNA and protein expression levels via quantitative PCR and Western blot.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Affected family members exhibited progressive lower limb weakness and muscle atrophy. Muscle biopsy revealed mild myopathic changes without reducing bodies. A heterozygous\n                      <jats:italic>FHL1<\/jats:italic>\n                      c.505T&gt;C (p.C169R) variant was identified in the proband and other affected family members, while her nephew carried a hemizygous variant. Bioinformatics analysis predicted the variant to be damaging, and structural analysis indicated altered secondary structure and reduced protein stability. While mRNA levels remained unchanged in transfected 293\u2009T cells, mutant\n                      <jats:italic>FHL1<\/jats:italic>\n                      protein expression was significantly reduced in this heterologous system.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      The\n                      <jats:italic>FHL1<\/jats:italic>\n                      c.505T&gt;C (p.C169R) variant is likely pathogenic and associated with a familial myopathy. The reduction in mutant protein expression may contribute to the disease mechanism. This finding expands the spectrum of\n                      <jats:italic>FHL1<\/jats:italic>\n                      -related myopathy reported in the Chinese population and underscores the importance of integrated genetic and clinical analyses for diagnosis.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjno-2025-001229","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T06:10:25Z","timestamp":1764569425000},"page":"e001229","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical and genetic analysis of a family with myopathy caused by an\n                    <i>FHL1<\/i>\n                    gene variant"],"prefix":"10.1136","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-1891-9685","authenticated-orcid":false,"given":"Shuyi","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoli","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianghong","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,11,30]]},"reference":[{"key":"2025113022102190000_7.2.e001229.1","doi-asserted-by":"publisher","DOI":"10.1016\/0168-9525(94)90034-5"},{"key":"2025113022102190000_7.2.e001229.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-1119(99)00125-0"},{"key":"2025113022102190000_7.2.e001229.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-1119(98)00302-3"},{"key":"2025113022102190000_7.2.e001229.4","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M512552200"},{"key":"2025113022102190000_7.2.e001229.5","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200804077"},{"key":"2025113022102190000_7.2.e001229.6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079551","article-title":"Identification of an FHL1 Protein Complex Containing Gamma-Actin and Non-Muscle Myosin IIB by Analysis of Protein-Protein Interactions","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS One"},{"key":"2025113022102190000_7.2.e001229.7","doi-asserted-by":"publisher","DOI":"10.1002\/mus.23500"},{"key":"2025113022102190000_7.2.e001229.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2007.09.004"},{"key":"2025113022102190000_7.2.e001229.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2009.07.015"},{"key":"2025113022102190000_7.2.e001229.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2007.09.013"},{"key":"2025113022102190000_7.2.e001229.11","first-page":"904","article-title":"Proteomic identification of FHL1 as the protein mutated in human reducing body myopathy","volume":"118","author":"Schessl","year":"2008","journal-title":"J Clin Invest"},{"key":"2025113022102190000_7.2.e001229.12","doi-asserted-by":"publisher","DOI":"10.1097\/NEN.0b013e3182a23506"},{"key":"2025113022102190000_7.2.e001229.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2010.06.017"},{"key":"2025113022102190000_7.2.e001229.14","first-page":"668","article-title":"Standards and guidelines for the interpretation of sequence variants","volume":"47","author":"Wang","year":"2017","journal-title":"Sci Sin Vitae"},{"key":"2025113022102190000_7.2.e001229.15","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/brain\/awn325","article-title":"Clinical, histological and genetic characterization of reducing body myopathy caused by mutations in FHL1","volume":"132","author":"Schessl","year":"2009","journal-title":"Brain (Bacau)"},{"key":"2025113022102190000_7.2.e001229.16","doi-asserted-by":"crossref","DOI":"10.1038\/s41525-024-00393-0","article-title":"Clinical application of next generation sequencing for Mendelian disease diagnosis in the Iranian population","volume":"9","author":"Abolhassani","year":"2024","journal-title":"NPJ Genom Med"},{"key":"2025113022102190000_7.2.e001229.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2011.01.001"},{"key":"2025113022102190000_7.2.e001229.18","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000341311.84347.a0"},{"key":"2025113022102190000_7.2.e001229.19","first-page":"147","article-title":"Childhood reducing body myopathy caused by FHL1 gene variation in a child","volume":"58","author":"Wei","year":"2020","journal-title":"Chin J Pediatr"},{"key":"2025113022102190000_7.2.e001229.20","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/s10038-019-0627-z","article-title":"FHL1-related clinical, muscle MRI and genetic features in six Chinese patients with reducing body myopathy","volume":"64","author":"Hu","year":"2019","journal-title":"J Hum Genet"},{"key":"2025113022102190000_7.2.e001229.21","first-page":"174","article-title":"Clinical characteristics of hereditary myopathy caused by four and a half LIM domains 1 gene mutation: an analysis of one family","volume":"22","author":"Li","year":"2023","journal-title":"Chin J Neuromed"},{"key":"2025113022102190000_7.2.e001229.22","first-page":"1349","article-title":"FHL1 gene mutation related late-onset reducing body myopathy in a Chinese family","volume":"56","author":"Cui","year":"2023","journal-title":"Chin J Neurol"},{"key":"2025113022102190000_7.2.e001229.23","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.nmd.2019.11.011","article-title":"FHL1-related myopathy may not be classified by reducing bodies in muscle biopsy","volume":"30","author":"Chen","year":"2020","journal-title":"Neuromuscul Disord"},{"key":"2025113022102190000_7.2.e001229.24","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/dds157"},{"key":"2025113022102190000_7.2.e001229.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2018.03.001"}],"container-title":["BMJ Neurology Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjno-2025-001229","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T06:10:27Z","timestamp":1764569427000},"score":1,"resource":{"primary":{"URL":"https:\/\/neurologyopen.bmj.com\/lookup\/doi\/10.1136\/bmjno-2025-001229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":25,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,11,30]]},"published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1136\/bmjno-2025-001229"],"URL":"https:\/\/doi.org\/10.1136\/bmjno-2025-001229","relation":{},"ISSN":["2632-6140"],"issn-type":[{"value":"2632-6140","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]}}}